Author Archives: Jon C. Ogg

Follow Jon here:
Google+

Will The Ritz-Carlton Yacht Collection Disrupt The Luxury Cruise Industry?

The cruise industry seems to just keep growing and growing over time. Meanwhile, the hotel industry has enjoyed its waves of annual growth and is now facing challenges from the ...
Read Full Story »

7 Speculative Analyst Stock Picks Called to Rise 100% to 400%

While summer is generally a time that most people think about vacations and time with their families, investors are parsing through new ideas and considering how they should be positioned ...
Read Full Story »

Top Analyst Upgrades and Downgrades: AK Steel, Altice USA, Biogen, Caterpillar, Gilead, Oracle and Many More

Stocks have recently hit all-time highs again, but the stock indexes seem to have gone sideways in recent days and they were looking for direction on a slow news Friday. ...
Read Full Story »

Does a Sell Rating on Cinemark Wreck All Movie Chains?

It was largely overlooked in the news this week that there may be some horrible developments happening in the movie theater chain operators. Movies are supposed to be hot during ...
Read Full Story »

Are Movie Theaters on Death’s Door?

Movies are supposed to be hot during the summer. On top of getting a break from the heat outside, that's when many of the annual blockbuster films are released by ...
Read Full Story »

The Top 20 S&P 500 Companies Buying Back Stock in 2017

Long-term investors have generally been a fan of stock buybacks and dividends. After all, dividends can account for about half of all shareholder returns over time. And buybacks can help ...
Read Full Story »

Top Analyst Upgrades and Downgrades: Abercrombie, Aqua Metals, CarMax, Oracle, Southwest Air, Valero, Walmart and More

Stocks may have hit all-time highs again, but the market has taken a bit of a pause and is looking for direction. The drop in oil prices has soured some ...
Read Full Story »

Companies Are Getting Smarter and More Selective on Buybacks and Dividends

Equity investors love two things on top of capital gains when it comes to investing over the long haul: stock buybacks and dividends. While dividends add to shareholder returns in ...
Read Full Story »

George Clooney Makes More on Tequila Than on Movies as Casamigos Sells to Diageo

If you think the appetite to acquire niche brands in beer, wine and alcohol is over, guess again. Diageo PLC (NYSE: DEO) announced that it has entered into a definitive ...
Read Full Story »

Does Eiger BioPharmaceuticals Really Have 400% Upside?

Liana Moussatos of Wedbush Securities assumed coverage of Eiger BioPharmaceuticals Inc. (NASDAQ: EIGR) with an Outperform rating. The old price target of $28 was also ratcheted up to $34. What ...
Read Full Story »

Top Analyst Upgrades and Downgrades: Abbott Labs, AMD, Chesapeake, Intel, PayPal, Target, Weatherford, Whiting Petroleum and Many More

Stocks hit all-time highs yet again this week, but the markets were directionless on Wednesday morning, with the S&P 500 down one point and the Dow up 11 points. The ...
Read Full Story »

How Much Sprint Might Actually Fetch in a Rumored Merger With T-Mobile US

If there is one merger target that has been rumored for years, one company that has already seen a failed merger in recent years, it's Sprint Corp. (NYSE: S). There ...
Read Full Story »

Credit Card Defaults Hitting 4-Year Highs

Whether an investor, a business owner or an average working person, every single one of us has to worry about the broad economic trends. We can all remember the pain ...
Read Full Story »

Large Insider Buying at Alexion Raises Investors’ Eyebrows

Most of the large biotech outfits in America have gone into a limbo mode. Alexion Pharmaceuticals Inc. (NASDAQ: ALXN) fits that bill despite having a $26.5 billion market cap. Is ...
Read Full Story »

Why JPMorgan Shares Could Catch Up and Outperform the Dow and S&P

JPMorgan Chase & Co. (NYSE: JPM) and the financials have still lagged the overall market performance so far in 2017. The Dow was up almost 9% and the S&P 500 ...
Read Full Story »